Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Treatments for urinary symptoms often cause ejaculatory problems.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Reducing phthalate exposure may help prevent early puberty in girls.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Scrotal rejuvenation treats aging-related changes in men's scrotum using methods like medication, hair transplantation, and surgery.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.